Roxana Mehran, M.D., FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: medicines company(MODEST), Medscape(MODEST), The Medicines Company(MODEST), Boston Scientific(MODEST), Cardiovascular Systems Inc(MODEST), Abbott Vascular(MODEST), Abiomed(MODEST), Roivant Sciences(MODEST), Volcano Corporation(MODEST), Spectranetics(MODEST) RESEARCH/RESEARCH GRANTS: AstraZeneca(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Eli Lilly/DSI(SIGNIFICANT), CSL Behring (SIGNIFICANT), Novartis Pharmaceuticals(SIGNIFICANT), Medtronic(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT), OrbusNeich(NONE), The Medicines Company(SIGNIFICANT) OTHER FINANCIAL BENEFIT: WebMD(MODEST), Wiley Blackwell Publishing Company(MODEST), Janssen Pharmaceuticals, Inc(MODEST), Osprey Medical(MODEST), Bristol-Myers Squibb Company (MODEST), Claret Medical(NONE), Elixir Medical(NONE)

View Full Disclosure